1. Cutaneous lymphocyte antigen (CLA) is a potential therapeutic target in cutaneous T cell lymphoma. (September 2022) Authors: Poglio, S; Péru, S; Prochazkova-Carlotti, M; Cherrier, F; Velazquez, J; Richard, E; Idrissi, Y; Cappellen, D; Azzi-Martin, L; Pham-Ledard, A; Beylot-Barry, M; Merlio, JP Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P04.12 Characteristics of IDH-mutant gliomas with non-canonical IDH mutations. (6th September 2019) Authors: Poetsch, L; Dehais, C; Frénel, J; Siegfried, A; Lacomme, S; Seizeur, R; Larrieu-Ciron, D; Cappellen, D; Loussouarn, D; Ferec, C; Eimer, S; Carpentier, C; Sanson, M; Delattre, J; Figarella-Branger, D; Ducray, F; Bronnimann, C Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗